MACQUARIE GROUP LTD - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 221 filers reported holding AMICUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$87,706,000
+0.9%
7,212,652
+4.2%
0.11%
+11.1%
Q2 2023$86,940,000
+9.3%
6,921,981
-3.5%
0.10%
+5.3%
Q1 2023$79,527,000
-6.4%
7,171,035
+3.1%
0.09%
-6.0%
Q4 2022$84,958,000
+18.3%
6,958,047
+1.2%
0.10%
+13.6%
Q3 2022$71,821,000
-1.2%
6,877,761
+1.6%
0.09%
+7.3%
Q2 2022$72,680,000
+17.3%
6,767,246
+3.4%
0.08%
+74.5%
Q1 2022$61,961,000
-14.8%
6,542,879
+3.9%
0.05%
-23.0%
Q4 2021$72,704,000
+19.6%
6,294,686
-1.1%
0.06%
+17.3%
Q3 2021$60,801,000
+0.3%
6,366,584
+1.2%
0.05%
+4.0%
Q2 2021$60,624,000
+7.8%
6,288,841
+10.4%
0.05%
-37.5%
Q1 2021$56,258,000
-25.9%
5,694,195
+73.2%
0.08%
-27.9%
Q4 2020$75,898,000
+622.7%
3,287,035
+342.0%
0.11%
+516.7%
Q3 2020$10,502,000
+456.5%
743,754
+494.4%
0.02%
+500.0%
Q2 2020$1,887,000
+37.4%
125,122
-15.8%
0.00%0.0%
Q1 2020$1,373,000
+0.4%
148,570
+5.7%
0.00%
+50.0%
Q4 2019$1,368,000140,5020.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,524,022$127,972,10812.11%
Perceptive Advisors 27,692,917$336,745,87011.23%
Redmile Group, LLC 16,944,621$206,046,5919.80%
Finepoint Capital LP 1,489,025$18,106,5449.02%
CM Management, LLC 450,000$5,472,0005.81%
Avoro Capital Advisors LLC 27,400,000$333,184,0005.20%
MPM BioImpact LLC 716,139$8,708,2502.32%
Artal Group S.A. 4,062,567$49,4012.12%
SECTORAL ASSET MANAGEMENT INC 803,464$9,770,1221.90%
GREAT POINT PARTNERS LLC 857,000$10,421,1201.90%
View complete list of AMICUS THERAPEUTICS INC shareholders